Objective: To determine the effectiveness of a care bundle, with a novel line maintenance procedure, in reducing the rate of central line-associated bloodstream infection (CLABSI) in the intensive care unit (ICU).
are an important source of morbidity, mortality and cost.
1 About 4000 CLABSIs occur in Australian intensive care units (ICUs) each year, with an estimated nationwide cost of $36.26 million and a mortality rate of 4%-20%. 2, 3 The importance placed on CLABSI and its prevention has prompted standardised monitoring for quality assurance and innovation of preventive strategies. 1, 4, 5 Care bundles focused on improving line insertion procedure have proven successful overseas. 1, 6 Local implementation of a similar care bundle to that used overseas across New South Wales proved successful, and prompted the Australian and New Zealand Intensive Care Society CLABSI Prevention Project. 7, 8 Despite these interventions, CLABSI rates range from 0.9 to 3.6 per 1000 central line days. 6, 7, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] The Victorian Healthcare Associated Infection Surveillance System (VICNISS) collects standardised ICU CLABSI rates for the state of Victoria. 21 Since 2006, the University Hospital Geelong (UHG) ICU has reported CLABSI rates to VICNISS.
An elevated reported CLABSI rate at UHG in 2007 and 2008 (3.8 and 3.6 , respectively, compared with the state average of 2.7 per 1000 central line days) 22 prompted development and introduction of a CLABSI prevention care bundle. Our care bundle used an effective line insertion procedure identified from previous studies, 1, 6, 7 but also incorporated a novel maintenance procedure. In this article, we report the effectiveness of this care bundle in a tertiary ICU in Victoria.
Methods
We undertook a before-and-after study, retrospectively accessing the pre-intervention data, at an adult, tertiary, 19-bed ICU that admits medical, surgical and cardiac surgical patients.
Ethics approval was obtained from the Barwon Health Research Review Committee. This project was performed as part of the authors' usual roles and no funding or subsidy was received. All of us had full access to the study data. All VICNISS-reported CLABSI cases were reviewed by one of us (D E) to confirm that they fulfilled the current VICNISS definition (Appendix 2). This definition is consistent with the internationally accepted O'Grady definition that has been previously applied. 7, 23 All confirmed CLABSIs were included in the analysis, irrespective of whether line insertion occurred in the ICU. Cohort demographic, basic clinical and microbiological data were collected from the hospital electronic database. Patient medical records of all VICNISS-reported CLABSI cases were reviewed to confirm CLABSI definition and collect additional clinical information. Finally, all positive blood cultures were blindly and independently reviewed by an infectious diseases specialist to identify any missing CLABSI cases.
Intervention

Statistical analysis
Data were analysed using SAS, version 9.4 (SAS Institute). All data were visually assessed for normality using histograms. The primary outcome (CLABSI events) was compared first as an overall comparison of proportions and presented as a relative risk with 95% confidence intervals and second as the number of CLABSI events per quarter using Poisson regression.
Comparisons of pre-and post-intervention periods were performed for categorical variables using χ 2 tests for equal proportions and reported as numbers (%). Normally distributed variables were compared using Student t tests and reported as mean (SD), and non-normally distributed data were compared using Wilcoxon rank-sum tests and reported as median (interquartile range). A twosided P of 0.05 was considered to be statistically significant.
Results
Patient cohort characteristics are detailed in Box 1. The post-intervention cohort was significantly younger (mean age, 59.4 years v 64.2 years; P < 0.001) with a higher mean illness severity score (Acute Physiology and Chronic Health Evaluation as a causative organism in the postintervention cohort.
Discussion
Our study describes a significant reduction in the CLABSI rate in a tertiary Australian Victorian ICU from a peak quarterly rate of 5.2 to zero after implementation of a care bundle that incorporated a novel line maintenance procedure. Overall, the CLABSI rate, per 1000 central line days, decreased from 2.2 in the preintervention period to 0.5 in the postintervention period. In real terms, the reduced CLABSI rate equates to 15 fewer cases of CLABSI for the post-intervention period with an estimated total reduction in ICU length of stay of 38 days, hospital length of stay of 113 days and resultant cost saving of about $210 000.
To our knowledge, this is the first time that a zero CLABSI rate has been achieved and sustained in an Australian ICU. Burrell and colleagues reported a CLABSI rate of 0.9/1000 central line days from several centres. 7 Department of Health data from Western Australia have shown similarly low CLABSI rates, but their processes were not reported. 5, 7, 24 The finding of clinical effectiveness after introduction of the care bundle suggests that the observed benefits are causally associated. It is plausible that the maintenance procedure was crucial in reducing CLABSI, given that zero CLABSI was achieved despite the inclusion of lines inserted outside the ICU. It remains possible that changes in the patient cohort or procedures relating to CLABSI surveillance could account for the observed changes. In particular, there were seven CLABSIs that did not meet definition criteria in the pre-intervention period compared with one in the post-intervention period, raising the possibility of previous overreporting. Otherwise, the identified post-intervention cohort changes when taken together are considered as predisposing to CLABSI. In addition, the central line days and blood cultures per patient do not support altered clinical practice as an explanation.
Our study's strengths include a large patient cohort with availability of population characteristics, a microbiological blood culture dataset, an independent review of all positive blood cultures, and the application of the current standard CLABSI definition across the entire study period. This reduces the likelihood that the observed change was driven by changes in non-infection control related clinical practices. This study is limited by a single-centre retrospective, observational design, limiting generalisability and the ability to establish causality. However, these limitations are largely comparable to prior similar studies. 6, 7, 25 Other limitations included potential confounding from lines inserted outside the ICU and the absence of adherence data for the individual components of our line maintenance procedure to show actual change in clinical practice. However, in our experience, the care bundle has been embedded into routine and has markedly improved clinical practice.
In conclusion, our study suggests that a central line care bundle with this novel line maintenance procedure can effectively reduce the CLABSI rate to zero and that this zero CLABSI rate can be sustained. Validation of our study by other centres, especially if performed prospectively, would further support our findings.
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